Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -8592.00x as of the fiscal period ended Thursday, December 31, 2020.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-8592.00x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 329 covered companies
CURRENT VS SECTOR MEDIAN
-204471.43%
vs the sector median at left
Amylyx Pharmaceuticals, Inc.
Market Cap
$3.09B
Interest Coverage Ratio
-8592.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.15B
Interest Coverage Ratio
-1.01x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.16B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.25B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.88B
Interest Coverage Ratio
-75.61x
TTM Avg
0.12x
3Y Avg
0.12x
5Y Avg
0.12x
Market Cap
$2.87B
Interest Coverage Ratio
7.88x
TTM Avg
5.24x
3Y Avg
5.24x
5Y Avg
5.24x
Market Cap
$2.87B
Interest Coverage Ratio
-0.59x
TTM Avg
11.23x
3Y Avg
11.23x
5Y Avg
11.23x
Market Cap
$3.44B
Interest Coverage Ratio
N/A
TTM Avg
407.95x
3Y Avg
407.95x
5Y Avg
407.95x
Market Cap
$2.69B
Interest Coverage Ratio
1.89x
TTM Avg
1.89x
3Y Avg
0.94x
5Y Avg
0.94x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | $3.09B | -8592.00x | N/A | N/A | N/A |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.15B | -1.01x | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | N/A | N/A | N/A | N/A |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.25B | N/A | N/A | N/A | N/A |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | -75.61x | 0.12x | 0.12x | 0.12x |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 7.88x | 5.24x | 5.24x | 5.24x |
| AtriCure, Inc. (ATRC)vs › | $2.87B | -0.59x | 11.23x | 11.23x | 11.23x |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.44B | N/A | 407.95x | 407.95x | 407.95x |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 1.89x | 1.89x | 0.94x | 0.94x |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 2.79x | 3.64x | 5.04x | 5.11x |
Interest Coverage
-8592.0x
Debt/Equity
0.02
Current Ratio
12.12
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2020-12-31 | -8592.00x |
